WHO世界卫生组织：2024年人乳头瘤病毒（HPV）疫苗产品选择的注意事项报告-第二版（英文版）

This document summarizes current technical and programmatic information on WHO-prequalified human papillomavirus (HPV) vaccine products in order to facilitate informed country choices for HPV vaccine introduction or product switch within immunization programmes. This second edition replaces the original document (28 April 2024).

Since 2009, five HPV vaccine products have been prequalified by WHO. They include three bivalent products (Cecolin®, manufactured by Xiamen Innovax Co. Ltd., an